Ability of Serratus Anterior Plane block in reducing post operative pain killer requirement after breast removal surgery

EFFICACY AND SAFETY OF ULTRASOUND GUIDED SERRATUS ANTERIOR PLANE BLOCK IN REDUCING POST-OPERATIVE OPIODS REQUIREMENT IN PATIENTS UNDERGOING MASTECTOMY- A RANDOMIZED CONTROL TRIAL STUDY - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064147

Enrollment

Registered

2024-03-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast Health Condition 2: C509- Malignant neoplasm of breast of unspecified site Health Condition 3: O- Medical and Surgical

Interventions

Intervention1: USG guided Serratus anterior plane block: With due approval from institutional ethical committee, the study will be conducted at Jawahar Lal Nehru Medical College, Ajmer, Rajasthan on p

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA 1 AND ASA 2. 2. Age 20 - 60 years of female sex. 3. Weighing between 40 and 75 kgs. Undergoing mastectomies under general anesthesia will be included in the stud

Exclusion criteria

Exclusion criteria: 1. Ineligible to provide informed consent 2. Younger than 20 years or older than 60 years of age. 3. Impaired kidney or renal functions history of alcohol or drug abuse. 4. History of chronic pain condition or daily intake of analgesics and corticosteriods. 5. Uncontrolled systemic disease (DM, HTN) 6. Pregnant or lactating. 7. Any condition in which some drugs are contraindicated and hypersensitivity.

Design outcomes

Primary

Measure	Time frame
Duration of AnalgesiaTimepoint: To assess the duration of analgesia from time of extubation to demand of first dose of rescue analgesic.	—

Secondary

Measure	Time frame
1. Total postoperative analgesic consumption. 2. Haemodynamic variables like HR, SBP, DBP, MBP, SPO2 intra operatively and post operatively. 3. Side effect if any. Timepoint: Every 5 minutes upto 30 minutes Baseline, 5 mins,10mins,30 mins, 45 mins, 60 mins, 90 mins, 120 mins and 150 mins	—

Countries

India

Contacts

Public ContactPandu Ranga Rao Bangaru

JLN Medical college, Ajmer, Rajasthan

veenapatodi@gmail.com9414008276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026